-
1
-
-
0029050563
-
Fetal origins of coronary heart disease
-
Barker D J P. Fetal origins of coronary heart disease. Br Med J 1995; 311: 171-174.
-
(1995)
Br Med J
, vol.311
, pp. 171-174
-
-
Barker, D.J.P.1
-
2
-
-
0029877455
-
Factors influencing the development of melatonin rhythmicity in humans
-
Kennaway D J, Goble F C, Stamp G E. Factors influencing the development of melatonin rhythmicity in humans. J Clin Endocrinol Metab 1996; 81: 1525-1532.
-
(1996)
J Clin Endocrinol Metab
, vol.81
, pp. 1525-1532
-
-
Kennaway, D.J.1
Goble, F.C.2
Stamp, G.E.3
-
3
-
-
0030668716
-
Could exogenous melatonin prevent sudden infant death syndrome?
-
Maurizi C P. Could exogenous melatonin prevent sudden infant death syndrome? Med Hypotheses 1997; 49: 425-427.
-
(1997)
Med Hypotheses
, vol.49
, pp. 425-427
-
-
Maurizi, C.P.1
-
4
-
-
0030577219
-
Fetal growth and coronary heart disease in South India
-
Stein C E, Fall C H D, Kumaran K, Osmond C, Cox V, Barker D J P. Fetal growth and coronary heart disease in South India. Lancet 1996; 348: 1269-1273.
-
(1996)
Lancet
, vol.348
, pp. 1269-1273
-
-
Stein, C.E.1
Fall, C.H.D.2
Kumaran, K.3
Osmond, C.4
Cox, V.5
Barker, D.J.P.6
-
5
-
-
0030577215
-
Mothers' pelvic size, fetal growth, and death from stroke and coronary heart disease in men in the UK
-
Martyn C N, Barker D J P, Osmond C. Mothers' pelvic size, fetal growth, and death from stroke and coronary heart disease in men in the UK. Lancet 1996; 348: 1264-1268.
-
(1996)
Lancet
, vol.348
, pp. 1264-1268
-
-
Martyn, C.N.1
Barker, D.J.P.2
Osmond, C.3
-
6
-
-
0029025330
-
Impaired nocturnal secretion of melatonin in coronary heart disease
-
Brugger P, Markti W, Herold M. Impaired nocturnal secretion of melatonin in coronary heart disease. Lancet 1995; 345: 1408.
-
(1995)
Lancet
, vol.345
, pp. 1408
-
-
Brugger, P.1
Markti, W.2
Herold, M.3
-
7
-
-
0029915378
-
Impaired nocturnal melatonin excretion and changes of immunological status in ischaemic stroke patients
-
Fiorina P, Lattuada G, Ponari O, Silvestrini C, Dall'Aglio P. Impaired nocturnal melatonin excretion and changes of immunological status in ischaemic stroke patients. Lancet 1996; 347: 692-693.
-
(1996)
Lancet
, vol.347
, pp. 692-693
-
-
Fiorina, P.1
Lattuada, G.2
Ponari, O.3
Silvestrini, C.4
Dall'Aglio, P.5
-
8
-
-
0028891537
-
Antioxidants and the prevention of coronary heart disease
-
Hoffman R M, Garewal H S. Antioxidants and the prevention of coronary heart disease. Arch Intern Med 1995; 155: 241-246.
-
(1995)
Arch Intern Med
, vol.155
, pp. 241-246
-
-
Hoffman, R.M.1
Garewal, H.S.2
-
9
-
-
0028128943
-
The oxidation hypothesis of atherosclerosis
-
Witztum J L. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344: 793-795.
-
(1994)
Lancet
, vol.344
, pp. 793-795
-
-
Witztum, J.L.1
-
10
-
-
0030055903
-
Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability
-
Bjorkerud S, Bjorkerud B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol 1996; 149: 367-380.
-
(1996)
Am J Pathol
, vol.149
, pp. 367-380
-
-
Bjorkerud, S.1
Bjorkerud, B.2
-
11
-
-
0029960080
-
Lagrost. Induction of apoptosis in endothelial cells treated with cholesterol oxides
-
Lizard G, Deckert V, Dubrez L, Moisant M, Gambert P. Lagrost. Induction of apoptosis in endothelial cells treated with cholesterol oxides. Am J Pathol 1996; 148: 1625-1638.
-
(1996)
Am J Pathol
, vol.148
, pp. 1625-1638
-
-
Lizard, G.1
Deckert, V.2
Dubrez, L.3
Moisant, M.4
Gambert, P.5
|